David Bassa
CEO
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
Cannamore Biotechs
Former names:
Cannabis-based Treatment Solutions
Stealth Mode
Cannamore Biotechs
Cannamore Biotechs Overview
CannaMore is a preclinical- and clinical-stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide.
The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases.
CannaMore is a portfolio company of BioSeedXL.
The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases.
CannaMore is a portfolio company of BioSeedXL.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Cannamore Biotechs Climate Tech relevance
null
Companies you might be interested in
Driven by Finder AI
-
Eybna TechnologiesTerpene | Wellness | Food & Beverages | Cannabis51-200 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
RNAbleModulating RNA Epitranscriptomics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar?
Primary sector
Total funding
Funding stage
Number of employees
Founded
Related Content
Lists. Maps. Reports
Team Members
DB
OA
GD
OT
TO
MM
Contact Team
Affiliated Organizations
(null)Web & social links
https://cannamorebio.com
Locations
Israel
Barukh Hirsch St 18, Bnei Brak, Israel
Offices Abroad
Photos & videos
(0)No Data, yet.
Sorry, no content found under this section.
Cannamore Biotechs Business
Sector
Primary:
Health Tech & Life Sciences
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)Cannamore Biotechs Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Non-Equity Funding
Mergers and Acquisitions
Cannamore Biotechs Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Program
Mar 2019
Hub
Name
BioSeedXL
Batch
1
Cannamore Biotechs News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Sep 22, 2022
www.healtheuropa.com
Driving medical cannabis-based therapies forward with biotech
undefined
Related Content
Cannamore Biotechs Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
-
Eybna TechnologiesTerpene | Wellness | Food & Beverages | Cannabis51-200 employees • Funding Stage: Mature
shared sectors
Also shared
Are these companies similar? -
DenovAI BiotechDynamic Protein Design11-50 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
RNAbleModulating RNA Epitranscriptomics1-10 employees • Funding Stage: Seed
shared sectors
Also shared
Are these companies similar? -
ImPact BiotechTargeted Treatment for Selective Tumor Ablation11-50 employees • Funding Stage: Pre-Funding
shared sectors
Also shared
Are these companies similar?
Cannamore Biotechs Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,